-
Partnership Seeks Lower-Cost Protein Drugs
A biotechnology enterprise and company aiming to make drugs at lower prices are collaborating on new lower-cost synthetic protein drugs.
-
Seed Stage Investors Raise $450M for New Fund
A venture capital company specializing in financing start-up enterprises at their earliest stages says it raised $450 million for its third venture fund.
-
Synthetic Antibody Company Goes Public in $230M Merger
A developer of synthetic antibodies for inflammatory and skin disorders is becoming a public company through a special purpose acquisition-merger.
-
Lab Checklist: What Makes a Great Laboratory?
Today, we will be discussing different aspects that every lab needs. From safety equipment to accuracy, we will cover all bases.
-
Infographic – Climate Disasters Rising for Next Gens
New research shows children born last year can expect to experience three times the number of adverse climate events in their lifetimes than earlier generations.
-
Elephant Genetic Codes to be Sequenced, Preserved
A biotechnology company using gene editing to preserve animal species is sequencing the genomes of three elephant varieties to help prevent their extinction.
-
Foundation Plans $1B for Longevity Research
A charitable foundation began work today supporting research on human longevity, with the goal of increasing lifespans to more than 120 years.
-
How to Future-Proof Your Business
Future-proofing your business and increasing its resilience is an excellent way to help your company to continue to be profitable both now and in the long term.
-
Genomic Analysis Shown to Detect Early Pancreatic Cancer
Analysis of genomic and protein indicators in blood samples is shown to detect pancreatic cancer in earlier stages, increasing chances of survival.
-
Trial Begins Testing RNA Therapy for Alcohol Disorder
A clinical trial is underway testing a therapy that silences genes to create reactions in people with alcohol use disorder to help them stop drinking.